Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3Withdrawn 2Unknown 2

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Pain 6Neoplasm Metastasis 6Bone Neoplasms 5Breast Neoplasms 3Prostatic Neoplasms 1Osteoporosis 1Hematologic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Ibandronic Acid × Clear all
NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

SWOG Cancer Research Network

Phase 3 Completed
6,097 enrolled 20 charts
Breast

Breast Neoplasms

NCT02616744 2019-10-22

BONADIUV

Azienda Ospedaliero-Universitaria Careggi

Phase 2 Completed
171 enrolled
Breast

Breast Neoplasms

NCT00196859 2014-07-17

Study in Elderly Patients With Early Breast Cancer (ICE)

GBG Forschungs GmbH

Phase 3 Completed
1,500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡